An EMA committee has given TiGenix&8217;s allogeneic stem cell therapy for Crohn&8217;s disease its backing to enter the market in Europe. TiGenix and its Japanese partner Takeda are developing a stem cell therapy for Crohn&8217;s disease &...
↧